Drug Type Small molecule drug |
Synonyms |
Mechanism EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists), PDGFRβ inhibitors(Platelet-derived growth factor receptor beta inhibitors), Tubulin inhibitors + [1] |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | US | - | |
Neoplasms | Discovery | US | - | |
Neoplasms | Discovery | US | - |